These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 11148177
1. Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. Dahl M, Nordestgaard BG, Lange P, Vestbo J, Tybjaerg-Hansen A. Clin Chem; 2001 Jan; 47(1):56-62. PubMed ID: 11148177 [Abstract] [Full Text] [Related]
2. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population. Dahl M, Tybjaerg-Hansen A, Lange P, Vestbo J, Nordestgaard BG. Ann Intern Med; 2002 Feb 19; 136(4):270-9. PubMed ID: 11848724 [Abstract] [Full Text] [Related]
3. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD. Sitkauskiene B, Serapinas D, Blanco I, Fernández-Bustillo E, Janciauskiene S, Sakalauskas R. Respir Med; 2008 Nov 19; 102(11):1654-8. PubMed ID: 18722101 [Abstract] [Full Text] [Related]
4. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. Turino GM, Barker AF, Brantly ML, Cohen AB, Connelly RP, Crystal RG, Eden E, Schluchter MD, Stoller JK. Am J Respir Crit Care Med; 1996 Dec 19; 154(6 Pt 1):1718-25. PubMed ID: 8970361 [Abstract] [Full Text] [Related]
5. SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ. Franciosi AN, Carroll TP, McElvaney NG. Thorax; 2021 Mar 19; 76(3):298-301. PubMed ID: 32917839 [Abstract] [Full Text] [Related]
6. IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency. Demeo DL, Campbell EJ, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard SI, Sandhaus RA, Stocks JM, Stoller JK, Strange C, Turino G, Silverman EK. Am J Respir Cell Mol Biol; 2008 Jan 19; 38(1):114-20. PubMed ID: 17690329 [Abstract] [Full Text] [Related]
7. Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD). Bartmann K, Fooke-Achterrath M, Koch G, Nagy I, Schütz I, Weis E, Zierski M. Eur J Respir Dis; 1985 Apr 19; 66(4):284-96. PubMed ID: 3874784 [Abstract] [Full Text] [Related]
8. α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Sørheim IC, Bakke P, Gulsvik A, Pillai SG, Johannessen A, Gaarder PI, Campbell EJ, Agustí A, Calverley PM, Donner CF, Make BJ, Rennard SI, Vestbo J, Wouters EF, Paré PD, Levy RD, Coxson HO, Lomas DA, Hersh CP, Silverman EK. Chest; 2010 Nov 19; 138(5):1125-32. PubMed ID: 20595457 [Abstract] [Full Text] [Related]
9. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency. Franciosi AN, Hobbs BD, McElvaney OJ, Molloy K, Hersh C, Clarke L, Gunaratnam C, Silverman EK, Carroll TP, McElvaney NG. Am J Respir Crit Care Med; 2020 Jul 01; 202(1):73-82. PubMed ID: 32197047 [Abstract] [Full Text] [Related]
10. The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction. Rahaghi FF, Sandhaus RA, Brantly ML, Rouhani F, Campos MA, Strange C, Hogarth DK, Eden E, Stocks JM, Krowka MJ, Stoller JK. COPD; 2012 Aug 01; 9(4):352-8. PubMed ID: 22506682 [Abstract] [Full Text] [Related]
11. Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency–related cirrhosis. Carey EJ, Iyer VN, Nelson DR, Nguyen JH, Krowka MJ. Liver Transpl; 2013 Dec 01; 19(12):1370-6. PubMed ID: 24019185 [Abstract] [Full Text] [Related]
12. Genetic and biochemical markers of obstructive lung disease in the general population. Dahl M. Clin Respir J; 2009 Apr 01; 3(2):121-2. PubMed ID: 20298391 [Abstract] [Full Text] [Related]
13. The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency: The Association Between Diagnostic Delay and Worsened Clinical Status. Tejwani V, Nowacki AS, Fye E, Sanders C, Stoller JK. Respir Care; 2019 Aug 01; 64(8):915-922. PubMed ID: 30914495 [Abstract] [Full Text] [Related]
14. Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease. Piloni D, Ottaviani S, Saderi L, Corda L, Baderna P, Barzon V, Balderacchi AM, Seebacher C, Balbi B, Albicini F, Corino A, Mennitti MC, Tirelli C, Spreafico F, Bosio M, Mariani F, Sotgiu G, Corsico AG, Ferrarotti I. Minerva Med; 2024 Feb 01; 115(1):23-31. PubMed ID: 37021471 [Abstract] [Full Text] [Related]
15. Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ Individuals. Lara B, Miravitlles M. COPD; 2015 May 01; 12 Suppl 1():27-31. PubMed ID: 25938288 [Abstract] [Full Text] [Related]
16. Alpha-1 Antitrypsin Deficiency and Tobacco Smoking: Exploring Risk Factors and Smoking Cessation in a Registry Population. Franciosi AN, Alkhunaizi MA, Woodsmith A, Aldaihani L, Alkandari H, Lee SE, Fee LT, McElvaney NG, Carroll TP. COPD; 2021 Feb 01; 18(1):76-82. PubMed ID: 33557645 [Abstract] [Full Text] [Related]
17. Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in alpha(1)-antitrypsin deficiency: the Copenhagen City Heart Study. Dahl M, Tybjaerg-Hansen A, Sillesen H, Jensen G, Steffensen R, Nordestgaard BG. Circulation; 2003 Feb 11; 107(5):747-52. PubMed ID: 12578879 [Abstract] [Full Text] [Related]
18. Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project. Martín T, Guimarães C, Esquinas C, Torres-Duran M, Turner AM, Tanash H, Rodríguez-García C, Corsico A, López-Campos JL, Bartošovská E, Stæhr Jensen JU, Hernández-Pérez JM, Sucena M, Miravitlles M. Respir Res; 2024 Jun 26; 25(1):260. PubMed ID: 38926693 [Abstract] [Full Text] [Related]
19. The protease inhibitor PI*S allele and COPD: a meta-analysis. Dahl M, Hersh CP, Ly NP, Berkey CS, Silverman EK, Nordestgaard BG. Eur Respir J; 2005 Jul 26; 26(1):67-76. PubMed ID: 15994391 [Abstract] [Full Text] [Related]
20. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups. Foreman MG, Wilson C, DeMeo DL, Hersh CP, Beaty TH, Cho MH, Ziniti J, Curran-Everett D, Criner G, Hokanson JE, Brantly M, Rouhani FN, Sandhaus RA, Crapo JD, Silverman EK, Genetic Epidemiology of COPD (COPDGene) Investigators * . Ann Am Thorac Soc; 2017 Aug 26; 14(8):1280-1287. PubMed ID: 28380308 [Abstract] [Full Text] [Related] Page: [Next] [New Search]